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ABSTRACT; 
Background; Birth asphyxia is a leading cause of mortality and morbidity in neonates in developing countries, 
with an incidence of 100-250/1000 live births compared to 5-10/1000 live births in the developed world. It 
remains a significant cause of loss of life and adverse developmental outcome. Objective; To compare 
magnesium sulphate therapy versus placebo in control of fits among newborns admitted with birth asphyxia 
along with fits at a tertiary care hospital. Material and Methods; All the study (n=260) participants of either sex 
who met inclusion of this study were who are admitted with birth asphyxia. Group A was study group and was 
treated with magnesium sulfate in a dose of 250 mg/kg initially within six hours of birth followed by 250 mg/kg 
at 24 and 48 h of birth while group B (control group) was not given MgSO4 therapy and were observed for 
control of fits and was given standard treatment. Results; Of these 260 study cases, 139 (53.5 %) were male 
patients while 121 (46.5 %) were female patients. Mean age of our study cases was 3.84 ± 1.47 hours. Of these 
260 study cases, 177 (68.1%) belonged to rural areas and 83 (31.9 %) belonged to urban areas. Of these 260 
study cases, home delivery was noted in 91 (35.0%), 149 (57.3%) in private clinics / hospital and 20 (7.7%) in 
teaching hospital. Mean gestational age of our study cases was 38.23 ± 2.38 and preterm births were noted in 91 
(35.0%) of our study cases. Of these 260 study cases, control of fits were noted in 173 (66.5%) while control of 
fits in group A were noted in 105 (80.8%) and in group B it was 68 (52.3%) (p = 0.000). Conclusion; Our study 
results support the use of Magnesium Sulphate in control of fits in children with birth asphyxia. Magnesium 
sulphate was safe, reliable and having no side effect so it can be used safely in these patients to reduce morbidity 
and mortality. All clinicians treating such patients can employ this treatment modality having safety and 
efficacy.  
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INTRODUCTION; 
Birth asphyxia is an insult to the fetus or newborn due to failure to breath or breathing poorly, leads to decrease 
oxygen perfusion to various organs 1. Birth asphyxia is a leading cause of mortality and morbidity in neonates in 
developing countries, with an incidence of 100-250/1000 live births compared to 5-10/1000 live births in the 
developed world. It remains a significant cause of loss of life and adverse developmental outcome 2 – 4. The 
major causes of neonatal deaths globally were estimated to be infections (35%), preterm births (28%) and birth 
asphyxia (23%). As large number of deliveries in the developing world takes place at home, there is no reliable 
data to precisely estimate the disease burden in countries like Pakistan. However, this figure is likely to be very 
high as two thirds of world’s neonatal mortality occurs in 10 developing countries. In Pakistan, over 5 million 
children are born each year. Of them 0.45 million die before first birthday and nearly half of these deaths occur 
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during the neonatal period 5, 6. In 2001, birth asphyxia was responsible for 35%, 14% and 11% of neonatal 
mortality in Lahore, Karachi and Khyber Pukhtunkhwa respectively 6, 7. 
Asphyxia leads to two types of cerebral insults: the primary neuronal injury that occurs at the time of the 
hypoxic–ischemic insult and the secondary neuronal injury that occurs over hours to even days following the 
accumulation of excessive intraneuronal calcium as a result of excitatory amino acid stimulation of the N-
methyl–D-aspartate (NMDA) cell receptors 8, 9. It has been shown that NMDA receptor antagonists block 
calcium ion entry and preserve neuronal function and structure. MK 801, a NMDA receptor antagonist, has been 
shown to be neuroprotective in immature animals with asphyxia, but is too toxic to be evaluated in the human 
neonate. Magnesium ion gates the NMDA channels in a voltage-dependent manner and may protect the brain 
from NMDA receptor-mediated injury 10. A study from Sri Lanka 11 has reported MgSO4 was effective in 
controlling of fits as fits, continued at 24 hours in 18.5 % in treated  neonates having birth asyphyxia while 
control group (without MgSO4) exhibited more fits 34.4%. 
The results will help us to offer this treatment modality to our patients which will decrease disease related 
morbidity and mortality. The results will help suffering families in relieving certain financial and psychological 
stress.  
Material and Methods; 
All the study (n=260) participants of either sex who meet inclusion of this study were enrolled from department 
of Pediatric medicine, DHQ Teaching hospital Sahiwal, Pakistan who were admitted with birth asphyxia. 
Patients with congenital heart diseases (ventricular septal defect, transposition of great arteries seen on 
echocardiography, multiple congenital anomalies like Down Syndrome (determined by physical examination) 
were excluded from our study. Patients were randomly divided in 2 groups (by draws method). Group A was 
study group and was treated with magnesium sulfate in a dose of 250 mg/kg initially within six hours of birth 
followed by 250 mg/kg at 24 and 48 h of birth while group B (control group) was not given MgSO4 therapy and 
were observed for control of fits and was given standard treatment as per hospital protocols. Age, gender, 
residential status and place of delivery were taken and noted in the proforma. The diagnosis was done by a senior 
pediatrician having 5 years experience after fellowship in pediatric medicine.  All the data was entered and 
analyzed using SPSS-20. Descriptive statistics was applied to calculate mean and standard deviation for age in 
hours. Frequencies and percentage were calculated for the categorical variables like gender of children, monthly 
family income, control of fits, place of delivery and residential status (Rural/Urban). Control of Fits was 
compared in both by applying chi-square test at level of significance of 0.05. 
 
RESULTS; 
Our study comprised of a total of 260 patients meeting inclusion criteria of our study. Of these 260 study cases, 
139 (53.5 %) were male patients while 121 (46.5 %) were female patients. Mean age of our study cases was 3.84 
± 1.47 hours (with minimum age of our study cases was 1 hour while maximum age was 6 hours). Mean age of 
the male patients was noted to be 3.61 ± 1.03 hours while that female patients was 2.96 ± 1.28 hours (p=0.531). 
Our study results have indicated that majority of our study cases i.e. 165 (63.5 %) were aged up to 3 hours. Of 
these 260 study cases, 177 (68.1%) belonged to rural areas and 83 (31.9 %) belonged to urban areas. Monthly 
family income up to Rs. 35000 was noted in 151 (58.1%) and more than Rs. 35000 was noted in 109 (41.9%) in 
our study cases. Of these 260 study cases, home delivery was noted in 91 (35.0%), 149 (57.3%) in private clinics 
/ hospital and 20 (7.7%) in teaching hospital. Vaginal deliveries were noted 179 (68.8%) while cesarean section 
deliveries were noted in 81 (31.2%). Mean gestational age of our study cases was 38.23 ± 2.38 and preterm 
births were noted in 91 (35.0%) of our study cases. Of these 260 study cases, control of fits were noted in 173 
(66.5%) while control of fits in group A control of fits were noted in 105 (80.8%) and in group B it was 68 
(52.3%) (p = 0.000).  
DISCUSSION; 
Asphyxia remains a common problem in neonatal units and is a significant cause of morbidity and death in term 
and preterm neonates. The incidence of asphyxia is estimated to be between 1 and 8 per 1000 live births. This 
wide range can be largely attributed to problems in selecting indicators to identify children with perinatal 
asphyxia 12, 13. 
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Our study comprised of a total of 260 patients meeting inclusion criteria of our study. Of these 260 study cases, 
139 (53.5 %) were male patients while 121 (46.5 %) were female patients. A study conducted in Kenya by Alaro 
et al  12 has also reported 60 % male gender predominance which is close to our study results. A study conducted 
by Medani et al  13 from Sudan has also reported 59 % male gender predominance which is similar to that of our 
study results. A study conducted by Chishty et al 14 has also reported male gender predominance with 2.6:1 male 
to female gender ratio which is in compliance with our study results. A study conducted by Malik et al 15 has also 
reported 78 % male gender predominance which is close to our study results. A study conducted by Afzal et al 16 
has also reported 60 % male gender predominance which is in compliance with our study results.  
Mean age of our study cases was 3.84 ± 1.47 hours (with minimum age of our study cases was 1 hour while 
maximum age was 6 hours). Mean age of the male patients was noted to be 3.61 ± 1.03 hours while that female 
patients was 2.96 ± 1.28 hours (p=0.531). Our study results have indicated that majority of our study cases i.e. 
165 (63.5 %) were aged up to 3 hours. A study conducted by Medani et al  13 from Sudan has also reported 
similar results. A study conducted in Kenya by Alaro et al  12 has also reported similar results. A study conducted 
by Chishty et al 14 has also reported 75 % cases were aged up to 24 hours of birth which is different from our 
study results, however our patients were all registered within first 6 hours as per our inclusion 
criteria/methodology. Of these 260 study cases, 177 (68.1%) belonged to rural areas and 83 (31.9 %) belonged to 
urban areas. Monthly family income up to Rs. 35000 was noted in 151 (58.1%) and more than Rs. 35000 was 
noted in 109 (41.9%) in our study cases.  Of these 260 study cases, home delivery was noted in 91 (35.0%), 149 
(57.3%) in private clinics / hospital and 20 (7.7%) in teaching hospital. Vaginal deliveries were noted 179 
(68.8%) while cesarean section deliveries were noted in 81 (31.2%). A study conducted by Medani et al  13 from 
Sudan has also reported similar results. A study conducted in Kenya by Alaro et al  12 has also reported similar 
results. A study conducted by Chishty et al 14 has also reported 23 % birth asphyxia newborns were born at 
Government hospitals which is close to our study results. A study conducted by Malik et al 15 has also reported 
similar results. A study conducted by Medani et al  13 from Sudan has also reported 56.4 % vaginal deliveries 
which is close to our study results. A study conducted in Kenya by Alaro et al  12 has also reported 33 % cesarean 
section deliveries which is in compliance with our study results. A study conducted by Chishty et al 14  reported 
only 16 % cesarean section deliveries in these patients which is quite lower than our study results. A study 
conducted by Afzal et al 16 has also reported 33 % cesarean section deliveries which is close to our study results.  
Mean gestational age of our study cases was 38.23 ± 2.38 and preterm births were noted in 91 (35.0%) of our 
study cases. A study conducted by Chishty et al 14 has also reported 39.18 weeks mean gestational age which is 
similar to that of our study results. A study conducted by Afzal et al 16 has also reported 27 % preterm births 
which is in compliance with our study results.  
Of these 260 study cases, control of fits were noted in 173 (66.5%) while control of fits in group A control of fits 
were noted in 105 (80.8%) and in group B it was 68 (52.3%) (p = 0.000). A study from Sri Lanka 11 has reported 
MgSO4 was effective in controlling of fits as fits were observed in 18.5 % (continued for 24 hours) in treated  
neonates having birth asyphyxia while control group (without MgSO4) exhibited more fits 34.4%. These 
findings are in compliance with our study.  
CONCLUSION; 
Our study results support the use of Magnesium Sulphate in control of fits in children with birth asphyxia. 
Magnesium sulphate was safe, reliable and having no side effect so it can be used safely in these patients to 
reduce morbidity and mortality. All clinicians treating such patients can employ this treatment modality having 
safety and efficacy.  
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